Inquiry to Berlin Senate raises doubts about validity of PCR test

“In response to a question from the Berlin House of Representatives, the Berlin Senate Administration takes a somewhat unclear position on the effectiveness of PCR tests.

The Senate Department of Health has confirmed that PCR tests are not actually capable of detecting an infection within the meaning of the Infection Protection Act. This is clear from the answer to a question by individual Member of Parliament Marcel Luthe.

The Senate Administration stated that in the context of the law, the test must be a “reproductive agent (virus, bacterium, fungus, parasite) or other biological transmissible agent that can cause infection or communicable disease in humans” in order to be considered a “pathogen”.

In response to the congressman’s question whether “a so-called PCR test is capable of distinguishing between a ‘replicable’ and a ‘nonreplicable’ virus,” the Senate Administration answered with a “no”.

In explaining why the Senate nevertheless bases its considerations and measures to protect against infection on PCR test results, the Senate replies: “Because the PCR test detects the presence of SARS-CoV-2 viruses. The presence of these viruses correlates with an infection with these viruses. This infection is relevant for the considerations of infection control”. Therefore, it could also be assessed in which way the SARS-CoV-2 “infections” would have developed.

Luthe is not convinced by these answers. He told the Berliner Zeitung: “It is now urgently time to act rationally and in accordance with the rule of law again. If even the Senate has to admit that the test numbers reported daily do not indicate an infection in the sense of the law, the ordinances also lack the basis. After all, no one can currently say whether and how many infections are actually present. The tests cost immense resources, are a billion-dollar business for the manufacturers, but are useless for fighting infections.”